GOLDMAN SACHS GROUP INC - CENTURY THERAPEUTICS INC ownership

CENTURY THERAPEUTICS INC's ticker is IPSC and the CUSIP is 15673T100. A total of 36 filers reported holding CENTURY THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of CENTURY THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$96,556
-29.3%
48,278
+11.7%
0.00%
Q2 2023$136,547
-25.7%
43,211
-18.4%
0.00%
Q1 2023$183,799
+18.8%
52,968
+75.7%
0.00%
Q4 2022$154,670
-25.6%
30,150
+43.2%
0.00%
Q3 2022$208,000
-3.7%
21,056
-18.3%
0.00%
Q2 2022$216,000
-17.2%
25,768
+24.2%
0.00%
Q1 2022$261,000
-11.8%
20,746
+11.2%
0.00%
Q4 2021$296,000
-80.9%
18,655
-64.7%
0.00%
Q2 2021$1,549,00052,8080.00%
Other shareholders
CENTURY THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 1,307,407$2,614,8140.81%
Casdin Capital, LLC 3,206,380$6,412,7600.71%
Parametrica Management Ltd 27,840$55,6800.09%
Avidity Partners Management LP 1,098,500$2,197,0000.09%
Deep Track Capital, LP 543,008$1,086,0160.04%
HARBOURVEST PARTNERS LLC 29,018$58,0360.02%
CORNERCAP INVESTMENT COUNSEL INC 51,520$103,0400.02%
Baker Brothers Advisors 1,149,340$2,298,6800.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 165,000$330,0000.01%
FEDERATED HERMES, INC. 615,982$1,231,9640.00%
View complete list of CENTURY THERAPEUTICS INC shareholders